$JAZZ Headlines A stock that protects your identity and

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$JAZZ Headlines

A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 11:15 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 1:56 a.m. Sept. 6, 2012 - MarketWatch.com
The bull market is starting to stray 12:02 a.m. Feb. 16, 2012 - The Trading Deck
Nasdaq sustains break to 11-year highs 11:31 a.m. Feb. 7, 2012 - Michael Ashbaugh
Nasdaq sustains break to 11-year highs 11:00 a.m. Feb. 7, 2012 - Michael Ashbaugh
January uptrend meets major resistance 11:15 a.m. Jan. 24, 2012 - Michael Ashbaugh
U.S. benchmarks hesitate at major resistance 10:49 a.m. Jan. 24, 2012 - Michael Ashbaugh

Mr. Market Loves Jazz Pharmaceuticals, Time To Sell 3:47 a.m. Today - Seeking Alpha
Jazz Pharma To Guide 2014 With New Drugs On Board 11:48 a.m. Feb. 24, 2014 - Investors Business Daily
Jazz Pharmaceuticals Moves Up In Market Cap Rank, Passing Waters 4:40 p.m. Feb. 20, 2014 - TheStreet.com
Insider Trading Alert - MJN, JAZZ And CLB Traded By Insiders 11:30 a.m. Feb. 18, 2014 - TheStreet.com
Biotech Remains on Fast Track 11:00 a.m. Feb. 18, 2014 - RealMoney.com
A Lean, Wary Post-Bailout Ireland Begets Rising Stocks 4:17 p.m. Feb. 14, 2014 - Investors Business Daily
IPO Preview: Concert Pharmaceuticals 1:00 a.m. Feb. 13, 2014 - Seeking Alpha
Top Ranked Healthcare ETF in Focus: XPH - ETF News And Commentary 8:01 a.m. Feb. 12, 2014 - Zacks.com
Bull of the Day: Endocyte (ECYT) - Bull of the Day 5:03 a.m. Feb. 12, 2014 - Zacks.com
Jazz Pharma Still Making Investors Sing 11:29 a.m. Feb. 11, 2014 - TheStreet.com
Actavis, Valeant, Jazz: New Roles For Specialty Pharma 1:12 p.m. Feb. 7, 2014 - Investors Business Daily
Jazz, Valeant Pace Highly Rated Ethical Drugs Group 4:21 p.m. Feb. 6, 2014 - Investors Business Daily
3 Health Care Stocks Dragging The Sector Down 12:03 p.m. Feb. 6, 2014 - TheStreet.com
IBD's Price, Volume Bars In Color Help Identify Bases 4:33 p.m. Feb. 3, 2014 - Investors Business Daily
Questcor Defies Market Turmoil, Works On New Base 4:49 p.m. Jan. 31, 2014 - Investors Business Daily
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
How To Find, Buy Leading Stocks, Not Laggards 4:02 p.m. Jan. 27, 2014 - Investors Business Daily
Analyst Team Sees Strong Biotech Buyout Market in 2014 10:35 a.m. Jan. 27, 2014 - 247WallSt.com


Jazz Pharmaceuticals plc Completes Tender Offer For Gentium S.p.A. Shares 8:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2013 Fourth Quarter and Full Year Financial Results on February 25, 2014 4:07 p.m. Feb. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension 4:05 p.m. Feb. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland 8:05 a.m. Feb. 10, 2014 - PR Newswire - PRF
CHD Bioscience Appoints Dr. Catherine Angell Sohn to its Board of Directors 9:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 2:24 a.m. Jan. 23, 2014 - PR Newswire - PRF
Critical Alerts For Vodafone, PetSmart, Gamestop, Constellation brands, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Jan. 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness 8:05 a.m. Jan. 13, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 8:00 a.m. Jan. 9, 2014 - PR Newswire
Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13 4:15 p.m. Jan. 6, 2014 - PR Newswire
Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
InVivo Names Mark Perrin as Its New Chief Executive Officer 4:30 p.m. Dec. 23, 2013 - BusinessWire
Gentium S.p.A. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Jazz Pharmaceuticals 11:12 a.m. Dec. 20, 2013 - BusinessWire
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share 4:48 p.m. Dec. 19, 2013 - GlobeNewswire
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share 4:43 p.m. Dec. 19, 2013 - PR Newswire
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals 8:00 a.m. Dec. 19, 2013 - PR Newswire
Quarterly Changes to the NASDAQ OMX Q-50 Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Corporate Directors From ON Semiconductor, Carpenter Technology and AARP Become NACD Fellows 9:01 a.m. Dec. 3, 2013 - GlobeNewswire
Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics 8:00 a.m. Nov. 28, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Parents Nationwide Rally for Youth Online Safety Imperative

Updated Category News Views 14

Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...

Continue Reading
Tragedy in Jordan: A Call for Unity and Support

Updated Category News Views 2

A Dark Day in Jordan It's a gut punch, hearing news of yet another brutal attack targeting the Christian community in Jordan's Karak province. This act of terror isn't just a regional dagger—it cuts deep into the fabric of shared humanity. On Friday, the tranquil air of a sacred gathering was shattered, leaving behind grief and a call to action for those who refuse to...

Continue Reading
Physician Retirement: New Book Rethinks the Transition

Updated Category News Views 3

The Shifting Sands of Physician Retirement These days, the notion of retirement for physicians resembles less a definitive stop sign and more an unpaved route riddled with unexpected turns. The trusty map of 'work for X years, then retire' is fading. A new guide, NEXT: Flourishing in the New World of Physician Retirement, by Charles R. Stoner, DBA, and Thomas M. Waits,...

Continue Reading
Molly Carlson Dives Into History on Icebergs

Updated Category News Views 4

Turning Icebergs Into Diving Platforms: Molly Carlson's Bold Leap You ever hear about someone diving off an iceberg? I hadn't either until Molly Carlson decided to take the plunge—literally. Bringing guts to an icy landscape wasn't part of most people's adventure checklist, but for her, it was a shakeup of epic proportions. On June 11, 2026, out at Twillingate,...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 1

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
CobbleStone Partners with Hatch: Impact on CLM Success

Updated Category News Views 5

Seeing CobbleStone Software team up with Hatch Advisory feels like stumbling across an old pal leading a promising venture down the innovation road. This partnership isn't just another handshaking ceremony—it's a real shift for the tech-adoption space, especially in the contract lifecycle management (CLM) domain, where CobbleStone already has quite the footprint....

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 3

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading
Hidden Assets Guide: Essential Tool for Attorneys

Updated Category News Views 4

Asset Searches: Why They Matter to Lawyers Some days you just have to get into the nitty-gritty of legal legwork, and today feels like one of those days. Asset Search USA has come out swinging with a practical guide that no attorney should ignore, especially if they're dealing with the shadowy world of hidden assets. What are we talking about here? We're talking about...

Continue Reading
Disorderly Magic: New Lithium Batteries Breakthrough

Updated Category News Views 4

Disorder in Structure: A Game-Changer? Lithium-ion batteries—yeah, the gizmos powering your fancy electric cars and gadgets—might have just hit their next big break, all thanks to a little chaos. Over in Chungcheong Province, South Korea, researchers at Hanbat National University are messing with the atomic structure of lithium-rich cathodes, and guess what? They're...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 6

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading

Top 5 Most Recently Viewed Articles

D.C. Bar Celebrates Top Workplace Recognition for 2025

Updated Category News Views 150

D.C. Bar Celebrates Top Workplace Recognition for 2025 The D.C. Bar is thrilled to share that it has earned a spot on the prestigious list of Top Workplaces for 2025, as awarded by the Washington Post. This acknowledgment highlights organizations that excel in employee satisfaction and engagement in the greater Washington, D.C. area. Robert Spagnoletti, the Chief...

Continue Reading
Elsevier Develops Unique AI Evaluation Framework for Healthcare

Updated Category News Views 492

Elsevier Establishes Innovative Evaluation Framework for AI Tools Elsevier, a front-runner in medical information and analytics, has introduced a pioneering evaluation framework aimed at assessing the efficacy and safety of generative AI clinical decision support tools. This significant advancement is a part of Elsevier Health's AI solutions portfolio, including the...

Continue Reading
Ken Paxton's Lawsuit Challenges Tylenol Safety Claims

Updated Category News Views 218

Overview of Legal Action Against Tylenol Texas Attorney General Ken Paxton has taken a bold step by filing a lawsuit against Johnson & Johnson (NYSE: JNJ) and Kenvue Inc (NYSE: KVUE), accusing both companies of misleading pregnant women regarding the safety of Tylenol. Despite extensive evidence hinting at a connection between acetaminophen, the active ingredient in...

Continue Reading
Investors Take Note: Encompass Health Faces Legal Scrutiny Ahead

Updated Category News Views 184

Understanding the Legal Situation Surrounding Encompass Health The Rosen Law Firm, recognized globally for advocating investor rights, has initiated an inquiry into potential claims concerning Encompass Health Corporation (NYSE: EHC). This investigation stems from serious allegations suggesting that the company may have provided materially misleading information to its...

Continue Reading
Myrtle.ai Enhances ML Inference with Microsecond Latencies

Updated Category News Views 126

Myrtle.ai Unveils VOLLO for Ultra-Low Latency Machine Learning Myrtle.ai, a trailblazer in the field of machine learning (ML) acceleration, is making significant strides with its latest development. The company has introduced support for the VOLLO inference accelerator on the NT400D1x series of SmartNICs from Napatech. This innovation is poised to redefine ML inference...

Continue Reading